Don’t miss the latest developments in business and finance.

Alkem Laboratories intimates of successful USFDA inspection of facility in St Louis

Image
Capital Market
Last Updated : Oct 30 2017 | 9:47 AM IST

Zero observations issued under Form 483

Alkem Laboratories announced that US FDA had conducted an inspection at the Company's manufacturing facility located at St Louis, USA from 23 October, 2017 to 27 October, 2017. At the end of the inspection, no Form 483 was issued.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Oct 30 2017 | 9:30 AM IST

Next Story